Closed
AHCM 312 02 IMM(PQQ) - Individualised immunotherapy medicine
Description
Austin Health is pleased to invite you to respond to this PQQ. Austin Health is seeking a supplier who can provide: Manufacture and supply of Autologous anti-CD19 CAR-T cell for therapy in relapsed CD19+ Diffuse large B cell lymphoma, primary mediast...
Categories
- Disease prevention and control (50%)
- Healthcare Services (50%)
Specification documents
1 documentSee every tender in full
One Premium plan covers every opportunity across Australia and New Zealand.
- Full details, briefings and documents
- Buyer and contact details
- Saved searches with full alerts
- Track opportunities
- Your full supplier profile